RU

GSK US

@GSKUS · Philadelphia and RTP · joined 03 Mar 2009

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://t.co/woIbYTUlEv

94 665Followers

970Following

11 115Posts total

4KViews on collected posts

Последние посты

GSK US@GSKUS24 Aug

#News for #Investors and #Media: Today, we announced the US FDA accepted the application for one of our immuno-oncology therapies for priority review. Learn more: https://t.co/ZrSf9EHCh5 https://t.co/Oq7v6Lq69d

0:07

1.5K views · 5 likes · 1 reposts · 0 replies Open on X →

GSK US@GSKUS28 Jul

On World Hepatitis Day, we’re raising awareness of viral hepatitis and recognizing the importance of early and more complete testing in hepatitis B. Learn more about complete testing at: https://t.co/ekh9rDyv9p #WorldHepatitisDay #HepB #HepatitisB #LiverHealth #TestingMatters

1:57

878 views · 2 likes · 0 reposts · 0 replies Open on X →

GSK US@GSKUS17 Jun

#News for #Media and #Investors: Today @US_FDA has approved our oral anti-infective for complicated urinary tract infections (cUTIs). With three million cUTIs treated annually in the US, this approval reflects our commitment to innovation in anti-infectives. Learn more: https:/

0:07

573 views · 2 likes · 1 reposts · 0 replies Open on X →

GSK US@GSKUS12 Jun

#News for #Investors and #Media: Today, we announced that the US FDA has granted regulatory designations for one of our therapies for the treatment of VEXAS syndrome. Learn more: https://t.co/BhBJ8aEkmL https://t.co/3Cp7rCvSnh

0:07

444 views · 1 likes · 0 reposts · 0 replies Open on X →

GSK US@GSKUS27 May

#News for #investors and #media: We're excited to be at #ASCO26 and #EHA2026, where we will share data on how we're delivering a meaningful impact for cancer patients today while innovating for tomorrow. Learn more: https://t.co/cq4r2CkLYB. https://t.co/PZ2SSOyRMQ

0:10

546 views · 2 likes · 0 reposts · 0 replies Open on X →

На фоне аккаунтов своего размера

2 постов за последние 90 дней рядом с диапазоном 10K–100K подписчиков. ниже своих по обоим показателям — и по охвату, и по отклику.

Медианные просмотры1 196этот аккаунт936медиана для 10K–100K

Охват, %1.26%этот аккаунт3.53%медиана для 10K–100K

Вовлечённость, %0.31%этот аккаунт1.51%медиана для 10K–100K

Показатель	Этот аккаунт	Медиана для 10K–100K	Отношение
Медианные просмотры на пост	1 196	936	1.28×
Охват (просмотры ÷ подписчики)	1.26%	3.53%	0.36×
Вовлечённость	0.31%	1.51%	0.21×

Другие в этом диапазоне → Сравнить с другим аккаунтом → Как считаются эти ориентиры →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

54627 May

44412 Jun

57317 Jun

87828 Jul

1.5K24 Aug

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.37%27 May

0.23%12 Jun

0.52%17 Jun

0.23%28 Jul

0.40%24 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.51%.

What the audience does

Likes70.6%12 in total

Reposts11.8%2 in total

Bookmarks17.6%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Похожие аккаунты